(Q36614135)

15 August 2017

1 reference

title

The evolving role of glycoprotein IIb/IIIa inhibitor therapy in contemporary care of acute coronary syndrome patients (English)

1 reference

15 August 2017

acute coronary syndrome

1 reference

2

Eric D Peterson

1 reference

15 August 2017

1

Pierluigi Tricoci

1 reference

15 August 2017

1 October 2006

1 reference

Journal of Interventional Cardiology

15 August 2017

1 reference

15 August 2017

19

1 reference

15 August 2017

449-455

1 reference

15 August 2017

5

1 reference

Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty

15 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00182.X

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00182.X

A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00182.X

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00182.X

Randomized, placebo-controlled trial of titrated intravenous lamifiban for acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00182.X

Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00182.X

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00182.X

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00182.X

Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00182.X

ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice g

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00182.X

Early use of glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute myocardial infarction: observations from the National Registry of Myocardial Infarction 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00182.X

An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00182.X

Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00182.X

Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00182.X

Angiographic findings in patients with refractory unstable angina according to troponin T status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00182.X

Association between duration of tirofiban therapy before percutaneous intervention and tissue level perfusion (a TACTICS-TIMI 18 substudy).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00182.X

Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00182.X

Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00182.X

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00182.X

Bivalirudin: a review of its use in patients undergoing percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00182.X

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00182.X

Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00182.X

A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00182.X

Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00182.X

A regulatory perspective on choice of margin and statistical inference issue in non-inferiority trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00182.X

Unstable Angina : An Etiologic Approach to Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00182.X

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00182.X

The Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial: A randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00182.X

10.1111/J.1540-8183.2006.00182.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17020570